Worg is a clinical stage biopharmaceutical company focusing on delivering transformative immunotherapies to effectively fight against allergic, autoimmune diseases and other indications with high unmet medical needs.
Worg is led by executive members from China, the United States and Europe who have extensive experience in the whole business chain of life science industry, esp. on executive management, CMC, pharmaceutical development, regulatory affairs, and commercialization. Core members were educated in prestigious universities and collected professional experience from well-known companies and institutes such as Roche, Johnson & Johnson, Alexion, Shire, US FDA, Aventis, GSK, Porton and Fosun.
Founded in 2018, Worg headquarters in Hangzhou, one of China’s biotech hubs and owns a subsidiary company in Basel, the Europe’s heart of pharmaceutical industry. Worg is rapidly expanding its global presence and aspires to become a fully integrated pharmaceutical company.
Through internal development and external partnering with flexible business models, Worg is building a pipeline for allergy and autoimmune diseases based on two technology platforms, PCFiT and Apitope. In addition, Worg is working on a molecular allergy diagnosis platform. Worg envisions to be one of the world’s leading companies in immunotherapy helping patients by novel, safe and effective treatments.
Worg is always looking for professionals with similar values, entrepreneurial spirit and dedication for improving patients’ health. We provide broad career opportunities, competitive salary, friendly working atmosphere and abundant training opportunities. For more information, please contact us by firstname.lastname@example.org.